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No major trial evaluating prone positioning for acute respiratory distress syndrome (ARDS) has incorporated a
high-positive end-expiratory pressure (high-PEEP) strategy despite complementary physiological rationales. We
evaluated generalizability of three recent proning trials to patients receiving a high-PEEP strategy. All trials
employed a relatively low-PEEP strategy. After protocol ventilator settings were initiated and the patient was
positioned per treatment assignment, post-intervention PEEP was not more than 5 cm H2O in 16.7 % and not
more than 10 cm H2O in 66.0 % of patients. Post-intervention PEEP would have been nearly twice the set
PEEP had a high-PEEP strategy been employed. Use of either proning or high-PEEP likely improves survival in
moderate-severe ARDS; the role for both concomitantly remains unknown.Introduction
Prone positioning has been used since the 1970s to
improve oxygenation in patients with acute respiratory
failure [1]. Several important physiological changes
occur with proning: recruitment of dependent lung
regions [2, 3], increased ventilation-perfusion matching
[4], optimized chest wall mechanics [5], decreased
pleural pressure gradient from non-dependent to
dependent regions [6, 7], and augmented drainage of
tracheobronchial secretions [8].
Given these effects, proning would seem likely to
benefit patients with acute respiratory distress syndrome
(ARDS). Indeed, the recent PROSEVA (Proning Severe
ARDS Patients) multicenter randomized trial demon-
strated significantly improved survival with proning for
moderate-severe ARDS [9]. This trial built on cumula-
tive experience from the prior decade of indeterminate
trials [10–15], which served to refine the target popula-
tion, intervention strategy, and co-interventions. Key
features of PROSEVA that collectively may explain the
observed benefit compared with prior trials include
enrollment of patients only with more severe ARDS
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lized low tidal volume ventilation, near-ubiquitous use of
continuous neuromuscular blockade, intervening early
in the ARDS course, and increased duration of prone
positioning [16].
High positive end-expiratory pressure (PEEP) has been
advocated as part of an “open lung” approach by citing a
rationale similar to that of proning—improving lung
homogeneity to minimize ventilator-induced lung injury
[16]. Although no large clinical trial to date has demon-
strated definitively a mortality benefit with high PEEP
[17–19], a meta-analysis of three such trials found sig-
nificantly increased survival and ventilator-free days
with high PEEP for moderate-severe ARDS [20]. As a
result, several recently completed and ongoing multi-
center clinical trials of ARDS have incorporated a
high-PEEP strategy [21–23], although this practice is
not universal [24–29].
No major randomized trial of prone versus supine
positioning has incorporated a high-PEEP strategy for
either study arm [16]. Thus, it is unclear to what extent
patients managed with a high-PEEP strategy may gain
benefit from prone positioning and vice versa. High
PEEP with supine positioning may offer benefit compar-
able to that of low PEEP with prone positioning [16];
additionally, the combination of high PEEP and proning
may be synergistic [30]. To explore this potentialis distributed under the terms of the Creative Commons Attribution 4.0
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a post-hoc analysis of data from recent clinical trials on
prone positioning to examine in detail the PEEP titration
strategies used and to determine whether PEEP would
have been meaningfully different had a high-PEEP strat-
egy been employed.
Methods
Corresponding authors from all clinical trials identified
in a recent meta-analysis on prone positioning for
ARDS [16] were contacted. De-identified patient-level
data from three of seven trials were ultimately pro-
vided [9, 11, 13], including the two largest proning
trials to date [9, 11]. One included trial enrolled pa-
tients with acute hypoxemic respiratory failure (PaO2/
FiO2 of not more than 300) who had an anticipated
duration of mechanical ventilation of more than
48 hours, of which a subgroup met criteria for ARDS
[11]. The other two trials enrolled only patients with
moderate-severe ARDS, requiring PaO2/FiO2 of not
more than 200 [13] and not more than 150 [9].
PEEP titration strategy
Clinical trial protocols were reviewed for PEEP titration
strategy. Individual patient PEEP settings were evaluated
at two predefined thresholds—not more than 5 cm H2O
and not more than 10 cm H2O—at each of two time
points: baseline and post-intervention. Baseline PEEP re-
fers to values documented after study enrollment but
prior to any study intervention, thus reflecting usual care
received by patients before the study. Post-intervention
PEEP refers to the first documented values after being
placed on protocol ventilator settings and positioned ei-
ther prone or supine per treatment assignment. To avoid
risk of informative censoring owing to death or liber-
ation from mechanical ventilation, later time points were
not evaluated.
Calculation of expected high PEEP
We also considered what PEEP would have been in the
proning trials had a high-PEEP protocol been used. This
hypothetical PEEP was calculated for each patient by
identifying the PEEP level from PEEP-FiO2 titration ta-
bles that corresponded to each individual’s actual preset
FiO2. PEEP-FiO2 titration tables were obtained from the
ALVEOLI (ARDS Network Assessment of Low tidal
Volume and elevated End-expiratory volume to Obviate
Lung Injury Trial) and LOVS (Lung Open Ventilation
Study) protocols, two multicenter trials that compared
high- versus low-PEEP strategies [17, 18]. When the ti-
tration protocol permitted more than one PEEP setting
for a given FiO2, the lower PEEP level was reported,
biasing toward smaller differences between set and
hypothetical high-PEEP values.Statistical analysis
Results are reported as mean ± standard deviation or
number (percentage) as appropriate. Differences be-
tween set PEEP and expected high PEEP were compared
by using the paired t test. Missing data were thought to
occur at random given the timing of our analyses imme-
diately after trial enrollment; thus, patients with missing
data were excluded from analysis. Statistical significance
was determined by using a two-sided alpha of 0.05.
Results
Patient-level data from 1365 of 1393 patients, spanning
three multicenter randomized trials of prone versus su-
pine positioning, were available and included. The study
protocol PEEP titration strategy differed among included
trials. In one trial, PEEP was titrated according to non-
protocolized usual care [11]. In another [13], PEEP was
targeted to 10–15 cm H2O, although this upper limit
could be exceeded in cases of refractory hypoxemia des-
pite an FiO2 of 1.0. In PROSEVA, PEEP was titrated ac-
cording to the low-PEEP arm of the US National Heart,
Lung, and Blood Institute ARDS Network ALVEOLI
trial [17].
Baseline PEEP was not more than 5 cm H2O in 21.8 %
of all participants in pooled analysis and in a similar pro-
portion (18.9 %) in PROSEVA specifically (Table 1).
After patients were placed on protocol ventilator settings
and positioned prone or supine per treatment assign-
ment, post-intervention PEEP was not more than 5 cm
H2O in 16.7 % of patients and not more than 10 cm
H2O in two thirds of patients (66.0 %) in pooled analysis.
In regard to PROSEVA, which restricted enrollment to
patients with PaO2/FiO2 of less than 150, post-
intervention PEEP was not more than 5 cm H2O in
2.1 % of patients and not more than 10 cm H2O in half
of patients (48.7 %). Neither mean post-intervention
PEEP nor the proportion of patients with post-
intervention PEEP of not more than 10 cm H2O dif-
fered significantly by treatment assignment in any of
the trials.
In regard to hypothetical high-PEEP values for all tri-
als, mean baseline and post-intervention PEEP both
would have doubled had either the ALVEOLI or LOVS
high-PEEP strategies been used (P < 0.001 for both com-
parisons with set PEEP) (Fig. 1). In the PROSEVA trial,
mean post-intervention set PEEP was 12 ± 3 cm H2O,
whereas mean expected PEEP under the ALVEOLI and
LOVS protocols was 20 ± 2 cm H2O (P < 0.001 for both
comparisons with set PEEP).
Discussion
The present analysis highlights the paucity of data on con-
comitant high PEEP with prone positioning. Given the
purported overlapping benefits to regional mechanics
Table 1 Oxygenation and positive end-expiratory pressure measurements before and after study intervention
Guerin et al. [11] (2004) Mancebo et al. [13] (2006) Guerin et al. [9] (2013) All studies combined
Baseline
FiO2 66 ± 21 82 ± 20 79 ± 16 71 ± 20
PaO2/FiO2 152 ± 59 145 ± 84 104 ± 25 136 ± 58
PEEP, cm H2O 8 ± 3 12 ± 2 10 ± 3 9 ± 4
PEEP ≤5 cm H2O, % 27.2 % 0 % 18.9 % 21.8 %
PEEP ≤10 cm H2O, % 85.8 % 29.4 % 62.6 % 72.7 %
Post-intervention
FiO2 59 ± 19 75 ± 20 73 ± 16 65 ± 20
PaO2/FiO2 179 ± 77 173 ± 88 153 ± 72 170 ± 77
PEEP, cm H2O 8 ± 3 13 ± 2 12 ± 3 10 ± 4
PEEP ≤5 cm H2O, % 28.0 % 0 % 2.1 % 16.7 %
PEEP ≤10 cm H2O, % 83.3 % 24.1 % 48.7 % 66.0 %
Data are presented as mean ± standard deviation or percentage of study participants
FiO2 fraction of inspired oxygen, PaO2 partial pressure of oxygen in arterial blood, PEEP positive end-expiratory pressure
Beitler et al. Critical Care  (2015) 19:436 Page 3 of 6afforded by both interventions, these data raise legitimate
concern about generalizability of existing clinical trial data
on prone positioning to patients receiving a high-PEEP
strategy. Our findings highlight the need for additional
research comparing prone positioning, high PEEP, and
both in combination for treatment of moderate-severe
ARDS.
The mechanisms by which high PEEP may protect
against lung injury are similar to those associated with
proning. Both therapies promote more homogenous
lung recruitment, minimizing local shear stress; reduce
cyclic opening/collapsing of potentially recruitable lung
units during tidal ventilation; and improve ventilation-
perfusion matching. Indeed, preclinical models have
demonstrated that both proning and PEEP mitigate
ventilator-induced lung injury [31–33]. Clinically, the
PROSEVA trial demonstrated definitively better survival
from moderate-severe ARDS with prone compared with
supine positioning when managed with a low-PEEP
strategy [9]. A similar survival benefit has been sug-
gested with a high-PEEP supine strategy, compared with
a low-PEEP supine strategy, for moderate-severe ARDS
[20]. No multicenter randomized trial testing a high-
versus low-PEEP strategy has demonstrated definitively a
survival benefit nor enrolled exclusively patients with
moderate-severe ARDS (PaO2/FiO2 of not more than
200). However, a meta-analysis of the three largest trials
found improved survival with high PEEP in the
subgroup of patients with PaO2/FiO2 of not more than
200 [20], comparable to the population enrolled in
PROSEVA. Thus, the overlapping physiological and
clinical effects of proning and high PEEP raise doubt
as to whether a proning low-PEEP strategy yields a
survival advantage compared with a high-PEEP supinestrategy; further studies are needed to address this
question.
Moreover, whether concomitant provision of high
PEEP and proning offers additional clinical benefit over
either alone is unknown. In patients with diffuse infil-
trates on chest computed tomography (CT), combin-
ation therapy improves oxygenation and reduces
intrapulmonary shunt compared with either monother-
apy [34]. Prone positioning may reduce chest wall com-
pliance [35], potentially necessitating higher PEEP to
offset these changes. A recent CT study of 24 patients
with ARDS found that cyclic atelectasis decreased only
when higher PEEP (15 versus 5 cm H2O) and prone po-
sitioning were applied together. Whereas each therapy
in isolation promoted lung recruitment, simultaneous
proning and higher PEEP also mitigated regional hyper-
inflation observed with higher PEEP during supine posi-
tioning. An individually titrated high-PEEP strategy in
combination with proning has not been studied rigor-
ously to date. The ideal combination therapy may re-
quire adjusting PEEP after each repositioning to account
for changes in chest wall and lung mechanics in the
prone versus supine position.
Importantly, the optimum approach to setting PEEP
remains undefined. In this study, high PEEP was esti-
mated by using PEEP-FiO2 titration tables of the
ALVEOLI and LOVS trials. Such an “open lung” strategy
was shown recently to achieve higher levels of PEEP in
patients with more lung recruitability as measured by
CT scan, whereas other methods—ExPress, stress index,
and esophageal manometry—had no association with
lung recruitability [36]. Most major clinical trials to date
have titrated PEEP according to severity of oxygenation
impairment by using an arbitrary PEEP-FiO2 table with
Fig. 1 Comparison of set PEEP used in proning clinical trials and
hypothetical PEEP that would have been required under the ALVEOLI
or LOVS high-PEEP protocols. Expected PEEP under high-PEEP
protocols was calculated by using individual patient FiO2 values.
When the study protocol permitted multiple PEEP levels for a
given FiO2, the lowest PEEP value was chosen to bias results toward
smaller difference between set and expected PEEP. a Baseline PEEP
values prior to study intervention. b First post-intervention PEEP values.
Column height and error bars represent mean and standard deviation,
respectively. #Significantly different than set PEEP at P < 0.05. ALVEOLI
ARDS Network Assessment of Low tidal Volume and elevated
End-expiratory volume to Obviate Lung Injury Trial, FiO2 fraction
of inspired oxygen, LOVS Lung Open Ventilation Study, PEEP positive
end-expiratory pressure
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insults and resultant biotrauma appear to be the primary
drivers of ventilator-induced lung injury [37]. Thus, we
believe that the optimum approach involves titrating
PEEP to minimize mechanical lung injury. Several
mechanics-based approaches have been proposed: setting
PEEP above the lower inflection point of the static
pressure-volume curve [38, 39], according to pleural pres-
sure (estimated by esophageal manometry) to achieve a
non-negative end-expiratory transpulmonary pressure
(airway minus pleural pressure) [23, 40], and according to
highest respiratory system compliance [41, 42] or lowest
driving pressure (airway end-inspiratory plateau pressure
minus PEEP) [43], among others. Mechanics-based
PEEP strategies yield different PEEP selections thanhigh PEEP-FiO2 tables [36]. To maximize synergy with
proning, a mechanics-based approach to PEEP adjustment
may be necessary to further improve lung homogeneity,
avoid overdistension or hemodynamic compromise, and
prevent cyclic opening/collapse of potentially recruitable
lung units [44]. Changes in chest wall compliance
(decreased when prone) and aerated lung volume
(increased when prone) following repositioning highlight
the apparent need to adjust PEEP after each position
change to optimize mechanics for lung injury prevention.
Some important limitations to the present study are of
note. First, although no included trial incorporated a
high-PEEP titration strategy, the particular PEEP strategy
used differs for each included study. Only the PROSEVA
trial used a PEEP-FiO2 titration table for all patients,
identical to the low-PEEP strategy employed in the
ALVEOLI trial. Second, our calculation of expected high
PEEP may overestimate what the true PEEP level would
have been had a high PEEP-FiO2 table been used. Ex-
pected PEEP was calculated by using a PEEP-FiO2 table,
although a mechanics-based approach is preferred in
our view. Increasing PEEP often improves oxygenation,
permitting a reduction in FiO2 while maintaining PaO2
or SpO2 (blood oxygen saturation measured by pulse
oximetry) goals. High PEEP occasionally also could
contribute to hemodynamic instability, particularly in
patients with high lung compliance in whom overdisten-
sion is likelier. These limitations, which would lower
PEEP, are offset in part by our reporting the lowest ex-
pected PEEP level allowed whenever the high-PEEP ti-
tration protocol permitted more than one PEEP setting
for a given FiO2. Third, it is unknown whether a clinic-
ally meaningful interaction between PEEP and prone
positioning exists, as simultaneous provision of these
therapies has never been studied in a clinical trial pow-
ered for patient-centered endpoints. Finally, it is unclear
whether high PEEP would have altered clinical outcomes
in either the prone or supine study arms, although exist-
ing data suggest a benefit with supine positioning in
moderate-severe ARDS [20].
Conclusions
Existing clinical trial data on proning may not be
generalizable to patients receiving high PEEP. Current
evidence supports the routine use of either proning or
high PEEP in moderate-severe ARDS. A prudent ap-
proach may be to tailor the choice of strategy to individ-
ual patient safety factors, relative contraindications, and
staff training/experience. Although concomitant use of
proning and high PEEP has never been studied in a clin-
ical trial with patient-centered endpoints, effects may be
synergistic. Future clinical trials are needed to compare
efficacy and safety of proning, high-PEEP, and both in
combination for moderate-severe ARDS.
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